Disrupted EZH2 expression has been implicated in several uterine diseases, including endometriosis, uterine fibroids, endometrial cancer, and other proliferative disorders [20,21,41,42,43,44,45]. Here, EZH2 is linked to uterine corpus leiomyoma.